326 related articles for article (PubMed ID: 24832022)
21. Clonal dissemination of extensively drug-resistant Acinetobacter baumannii producing an OXA-23 β-lactamase at a teaching hospital in Shanghai, China.
Li Y; Guo Q; Wang P; Zhu D; Ye X; Wu S; Wang M
J Microbiol Immunol Infect; 2015 Feb; 48(1):101-8. PubMed ID: 24863499
[TBL] [Abstract][Full Text] [Related]
22. Treatment Outcomes of Colistin- and Carbapenem-resistant Acinetobacter baumannii Infections: An Exploratory Subgroup Analysis of a Randomized Clinical Trial.
Dickstein Y; Lellouche J; Ben Dalak Amar M; Schwartz D; Nutman A; Daitch V; Yahav D; Leibovici L; Skiada A; Antoniadou A; Daikos GL; Andini R; Zampino R; Durante-Mangoni E; Mouton JW; Friberg LE; Dishon Benattar Y; Bitterman R; Neuberger A; Carmeli Y; Paul M;
Clin Infect Dis; 2019 Aug; 69(5):769-776. PubMed ID: 30462182
[TBL] [Abstract][Full Text] [Related]
23. Antimicrobial efficacy of doripenem and its combinations with sulbactam, amikacin, colistin, tigecycline in experimental sepsis of carbapenem-resistant Acinetobacter baumannii.
Dinc G; Demiraslan H; Elmali F; Ahmed SS; Alp E; Doganay M
New Microbiol; 2015 Jan; 38(1):67-73. PubMed ID: 25742149
[TBL] [Abstract][Full Text] [Related]
24. Intravenous colistin combination antimicrobial treatment vs. monotherapy: a systematic review and meta-analysis.
Vardakas KZ; Mavroudis AD; Georgiou M; Falagas ME
Int J Antimicrob Agents; 2018 Apr; 51(4):535-547. PubMed ID: 29288723
[TBL] [Abstract][Full Text] [Related]
25. Treatment of Acinetobacter infections.
Michalopoulos A; Falagas ME
Expert Opin Pharmacother; 2010 Apr; 11(5):779-88. PubMed ID: 20210684
[TBL] [Abstract][Full Text] [Related]
26. In vitro activity of the novel fluorocycline TP-6076 against carbapenem-resistant Acinetobacter baumannii.
Seifert H; Stefanik D; Olesky M; Higgins PG
Int J Antimicrob Agents; 2020 Jan; 55(1):105829. PubMed ID: 31669740
[TBL] [Abstract][Full Text] [Related]
27. In vitro activity of tigecycline in combination with various antimicrobials against multidrug resistant Acinetobacter baumannii.
Principe L; D'Arezzo S; Capone A; Petrosillo N; Visca P
Ann Clin Microbiol Antimicrob; 2009 May; 8():18. PubMed ID: 19460166
[TBL] [Abstract][Full Text] [Related]
28. Comparison of colistin and colistin/sulbactam for the treatment of multidrug resistant Acinetobacter baumannii ventilator-associated pneumonia.
Kalin G; Alp E; Akin A; Coskun R; Doganay M
Infection; 2014 Feb; 42(1):37-42. PubMed ID: 23828559
[TBL] [Abstract][Full Text] [Related]
29. In-Vitro Assessment Of The Therapeutic Potential Of Polymyxins And Tigecycline Against Multidrugresistant Acinetobacter Isolates From Infected Wounds.
Khurshid M; Rashid A; Husnain M; Rasool MH; Waqas U; Saeed M; Naeem M; Sohail M
J Ayub Med Coll Abbottabad; 2020; 32(4):459-464. PubMed ID: 33225644
[TBL] [Abstract][Full Text] [Related]
30. High mortality rates among solid organ transplant recipients infected with extensively drug-resistant Acinetobacter baumannii: using in vitro antibiotic combination testing to identify the combination of a carbapenem and colistin as an effective treatment regimen.
Shields RK; Kwak EJ; Potoski BA; Doi Y; Adams-Haduch JM; Silviera FP; Toyoda Y; Pilewski JM; Crespo M; Pasculle AW; Clancy CJ; Nguyen MH
Diagn Microbiol Infect Dis; 2011 Jun; 70(2):246-52. PubMed ID: 21353436
[TBL] [Abstract][Full Text] [Related]
31. Multidrug resistant and extensively drug resistant Acinetobacter baumannii hospital infection associated with high mortality: a retrospective study in the pediatric intensive care unit.
Shi J; Sun T; Cui Y; Wang C; Wang F; Zhou Y; Miao H; Shan Y; Zhang Y
BMC Infect Dis; 2020 Aug; 20(1):597. PubMed ID: 32787942
[TBL] [Abstract][Full Text] [Related]
32. In vitro activities of rifampin, colistin, sulbactam and tigecycline tested alone and in combination against extensively drug-resistant Acinetobacter baumannii.
Dong X; Chen F; Zhang Y; Liu H; Liu Y; Ma L
J Antibiot (Tokyo); 2014 Sep; 67(9):677-80. PubMed ID: 25095805
[TBL] [Abstract][Full Text] [Related]
33. Emergence of tigecycline and colistin resistance in Acinetobacter species isolated from patients in Kuwait hospitals.
Al-Sweih NA; Al-Hubail MA; Rotimi VO
J Chemother; 2011 Feb; 23(1):13-6. PubMed ID: 21482488
[TBL] [Abstract][Full Text] [Related]
34. Outcomes in patients infected with carbapenem-resistant Acinetobacter baumannii and treated with tigecycline alone or in combination therapy.
Guner R; Hasanoglu I; Keske S; Kalem AK; Tasyaran MA
Infection; 2011 Dec; 39(6):515-8. PubMed ID: 21789524
[TBL] [Abstract][Full Text] [Related]
35. The clinical profile and outcomes of adult patients given intravenous colistin for multidrug-resistant gram negative infections in a Philippine tertiary hospital.
Li KL; Abad CLR
Int J Infect Dis; 2020 Apr; 93():9-14. PubMed ID: 31978579
[TBL] [Abstract][Full Text] [Related]
36. Comparative in vitro antimicrobial susceptibilities and synergistic activities of antimicrobial combinations against carbapenem-resistant Acinetobacter species: Acinetobacter baumannii versus Acinetobacter genospecies 3 and 13TU.
Sheng WH; Wang JT; Li SY; Lin YC; Cheng A; Chen YC; Chang SC
Diagn Microbiol Infect Dis; 2011 Jul; 70(3):380-6. PubMed ID: 21558048
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of monotherapy and combined antibiotic therapy for carbapenem-resistant Acinetobacter baumannii pneumonia in an immunosuppressed mouse model.
Song JY; Cheong HJ; Lee J; Sung AK; Kim WJ
Int J Antimicrob Agents; 2009 Jan; 33(1):33-9. PubMed ID: 18835761
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and safety profile comparison of colistin and tigecycline on the extensively drug resistant Acinetobacter baumannii.
Kwon SH; Ahn HL; Han OY; La HO
Biol Pharm Bull; 2014; 37(3):340-6. PubMed ID: 24583855
[TBL] [Abstract][Full Text] [Related]
39. Treatment options for carbapenem-resistant and extensively drug-resistant Acinetobacter baumannii infections.
Viehman JA; Nguyen MH; Doi Y
Drugs; 2014 Aug; 74(12):1315-33. PubMed ID: 25091170
[TBL] [Abstract][Full Text] [Related]
40. In vitro pharmacodynamics of human-simulated exposures of ampicillin/sulbactam, doripenem and tigecycline alone and in combination against multidrug-resistant Acinetobacter baumannii.
Housman ST; Hagihara M; Nicolau DP; Kuti JL
J Antimicrob Chemother; 2013 Oct; 68(10):2296-304. PubMed ID: 23710070
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
